Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron

Author:

Bell GC1,Caudle KE2,Whirl-Carrillo M3,Gordon RJ4,Hikino K5,Prows CA6,Gaedigk A7,Agundez JAG89,Sadhasivam S1011,Klein TE3,Schwab M121314

Affiliation:

1. Personalized Medicine Program; Mission Health; Asheville North Carolina USA

2. Department of Pharmaceutical Sciences; St. Jude Children's Research Hospital; Memphis Tennessee USA

3. Department of Genetics; Stanford University; Stanford California USA

4. University of California, San Diego, Department of Anesthesiology; San Diego California USA

5. Committee on Clinical Pharmacology and Pharmacogenomics; University of Chicago; Chicago Illinois USA

6. Division of Human Genetics, Division of Patient Services; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio USA

7. Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation; Children's Mercy-Kansas City; Kansas City Missouri USA

8. Department of Pediatrics; University of Missouri-Kansas City; Kansas City Missouri USA

9. Department of Pharmacology; University of Extremadura; Cáceres Spain

10. Department of Pediatrics, College of Medicine; University of Cincinnati; Cincinnati Ohio USA

11. Department of Anesthesia; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio USA

12. Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany, and University of Tübingen; Germany

13. Department of Clinical Pharmacology; University Hospital Tübingen; Tübingen Germany

14. Department of Pharmacy and Biochemistry; University of Tübingen; Tübingen Germany

Funder

National Institutes of Health

PharmGKB

EU HB020 UPGx

Robert Bosch Stiftung

National Institutes of Health eMERGE Network Phase III

Cincinnati Children's Hospital Medical Center

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference30 articles.

1. Gene-specific information tables for CYP2D6 https://www.pharmgkb.org/page/cyp2d6RefMaterials 2016

2. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update;Crews;Clin. Pharmacol. Ther.,2014

3. The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype;Gaedigk;Clin. Pharmacol. Ther.,2008

4. Prediction of CYP2D6 phenotype from genotype across world populations;Gaedigk;Genet. Med.,2016

5. Practice guidelines for postanesthetic care: an updated report by the American Society of Anesthesiologists Task Force on Postanesthetic Care;Apfelbaum;Anesthesiology,2013

Cited by 148 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3